Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128309 · ClinicalTrials.gov registry record · NA
Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain
A NA study of Generalized Anxiety Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT01128309: Completed NA study of Generalized Anxiety Disorder, sponsored by Massachusetts General Hospital.
NCT01128309 is a NA study of Generalized Anxiety Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 29 participants, below the 214-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01128309, a NA study of Generalized Anxiety Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to test whether Generalized Anxiety Disorder (GAD) patients that participate in a Stress Reduction Intervention show a brain activation pattern (assessed by MRI) indicative of improved emotion regulation compared to an active control intervention.
Primary Outcome
BOLD functional MRI and structural MRI
Conditions Studied
Interventions
- BEHAVIORAL Stress Reduction Intervention
- BEHAVIORAL Active Control intervention
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01128309 record still lists
NCT01128309 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 214-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Generalized Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which Stress Reduction Intervention is the first listed.
NCT01128309 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01128309 about?
NCT01128309 is a clinical study titled "Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain". The aim of the study is to test whether Generalized Anxiety Disorder (GAD) patients that participate in a Stress Reduction Intervention show a brain activation pattern (assessed by MRI) indicative of improved emotion regulation compared to an active control intervention.
What is the current status of trial NCT01128309?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2010-05. Estimated completion is 2011-04.
What conditions does trial NCT01128309 study?
This clinical trial studies the following conditions: Generalized Anxiety Disorder.
What interventions are being tested in trial NCT01128309?
The interventions under investigation include: Stress Reduction Intervention (BEHAVIORAL), Active Control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01128309?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01128309 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Generalized Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01128309's enrollment target sits among peer trials
29 47th of 48 higher than 2 of 48 other Generalized Anxiety Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Generalized Anxiety Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
RECRUITING · NA
-
Massage for GAD: Neuroimaging and Clinical Correlates of Response
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia